142 related articles for article (PubMed ID: 32238697)
21. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335
[TBL] [Abstract][Full Text] [Related]
23. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
24. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
26. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
27. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
[TBL] [Abstract][Full Text] [Related]
28. The PPARβ/δ agonist GW0742 modulates signaling pathways associated with cardiac myocyte growth via a non-genomic redox mechanism.
Galatou E; Kelly T; Lazou A
Mol Cell Biochem; 2014 Oct; 395(1-2):145-54. PubMed ID: 24939361
[TBL] [Abstract][Full Text] [Related]
29. PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.
Alvarez-Guardia D; Palomer X; Coll T; Serrano L; Rodríguez-Calvo R; Davidson MM; Merlos M; El Kochairi I; Michalik L; Wahli W; Vázquez-Carrera M
Biochim Biophys Acta; 2011 Feb; 1811(2):59-67. PubMed ID: 21070867
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
Sharma AK; Sk UH; He P; Peters JM; Amin S
Bioorg Med Chem Lett; 2010 Jul; 20(14):4050-2. PubMed ID: 20542425
[TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
32. RNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cells.
Savage SR; McCollum GW; Yang R; Penn JS
Mol Vis; 2015; 21():568-76. PubMed ID: 26015769
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Péchery A; Fauconnet S; Bittard H; Lascombe I
Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
[TBL] [Abstract][Full Text] [Related]
34. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Aleshin S; Strokin M; Sergeeva M; Reiser G
Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
[TBL] [Abstract][Full Text] [Related]
36. PPARβ/δ agonist GW501516 inhibits TNFα-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes.
Kim WJ; Lee W; Jung Y; Jang HJ; Kim YK; Kim SN
Biochem Biophys Res Commun; 2019 Mar; 510(4):621-628. PubMed ID: 30739791
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
Takeda S; Okajima S; Miyoshi H; Yoshida K; Okamoto Y; Okada T; Amamoto T; Watanabe K; Omiecinski CJ; Aramaki H
Toxicol Lett; 2012 Nov; 214(3):314-9. PubMed ID: 22963825
[TBL] [Abstract][Full Text] [Related]
38. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells.
Thulasiraman P; McAndrews DJ; Mohiudddin IQ
BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
40. Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.
Wang C; Zhou G; Zeng Z
Chin Med J (Engl); 2014; 127(11):2129-37. PubMed ID: 24890166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]